StockClub

PBSV

PBSVPharma-Bio Serv, Inc.$ --
Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc.

PBSV

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 01/31/2026FY2026 Q1
Revenue
2,295M USD
YoY +92763.5%
Operating Income
-0M USD
YoY -2.5%
Net Income
0M USD
YoY +285.0%
EPS
0$
YoY -99.6%

Revenue

$2.3B
FY2024 Q2$4.8M
$4.8M
Q2
FY2024 Q3$7.2M
$7.2M
Q3
FY2024 Q4$9.5M
$9.5M
Q4
FY2025 Q1$2.5M
$2.5M
Q1
FY2025 Q2$4.9M
$4.9M
Q2
FY2025 Q3$2B
$2B
Q3
FY2025 Q4$2B
$2B
Q4
FY2026 Q1$2.3B
$2.3B
Q1
Actual
+$2.3B (+92763.5%)

Net Income

$32,860
FY2024 Q2$-484,536
$-484,536
Q2
FY2024 Q3$-793,730
$-793,730
Q3
FY2024 Q4$-777,619
$-777,619
Q4
FY2025 Q1$8,536
$8,536
Q1
FY2025 Q2$103,889
$103,889
Q2
FY2025 Q3$-100,361
$-100,361
Q3
FY2025 Q4$-100,463
$-100,463
Q4
FY2026 Q1$32,860
$32,860
Q1
Actual
+$24,324 (+285.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$21.6M
Est:$21M
FY2020BEAT
$21.6M
FY2021BEAT
Actual:$20.1M
Est:$20M
FY2021BEAT
$20.1M
FY2022BEAT
Actual:$19.4M
Est:$19.3M
FY2022BEAT
$19.4M
FY2023MISS
Actual:$17M
Est:$18.4M
FY2023MISS
$17M
FY2024MISS
Actual:$9.5M
Est:$12.2M
FY2024MISS
$9.5M
FY2025BEAT
Actual:$9M
Est:$9M
FY2025BEAT
$9M

Analyst Estimates

No forecast data